Figure 6. Correlation of the mRNA expression levels of the prognostic ERG signature with demographic and clinicopathological characteristics of patients with LUAD. (A) CTSL and TNM stage. (B) FSCN1 and TNM stage. (C) HGF and T stage. (D) ITGB1 and T stage. (E) CTSL and N stage. (F) FSCN1 and N stage. (G) FSCN1 and age. (H) FUT4 and sex. (I) ITGB1 and sex.